Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
The first month-by-month analysis of malnutrition in children of preschool age in Gaza reveals the acute impact of aid restrictions and conflict — with the most recent estimates showing more than 50,000 children severely malnourished.
The future of HIV research — and of the USA’s scientific leadership — depends on bold, sustained action in defense of discovery, investment, and innovation.
A study shows that creativity enhances brain health by improving connectivity in age-vulnerable regions, highlighting the importance of supporting creative activities in public health strategies.
Baby wraps treated with the insecticide permethrin reduced the incidence of malaria in infants by 66%, according to a randomized controlled trial in Uganda.
After years of stigma, psychedelic compounds are edging closer to regulatory approval, with pivotal trials in tough-to-treat depression and anxiety underway.
A working group of Academia Europaea proposes the addition of a ‘ring diagram’ in clinical publications for the quick evaluation of translational implications.
Obesity and associated complications can be managed by obesity medications, prompting the revision of criteria for the diagnosis and staging of this disease.
The US Food and Drug Administration (FDA) is at a crossroads. There is an urgent need to strengthen the integrity of drug approvals and rejections by diffusing the decision-making authority of individual officials and improving transparency when disagreements arise.
Patients with obesity achieved significant weight loss and cardiometabolic benefits with oral orforglipron — offering a potential alternative to injectable GLP-1 receptor agonists.
